Natera Basic EPS 2014-2024 | NTRA

Natera annual/quarterly basic eps history and growth rate from 2014 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
  • Natera basic eps for the quarter ending June 30, 2024 was $-0.30, a 69.07% decline year-over-year.
  • Natera basic eps for the twelve months ending June 30, 2024 was $-2.44, a 49.38% decline year-over-year.
  • Natera annual basic eps for 2023 was $-0.004B, a 32.14% decline from 2022.
  • Natera annual basic eps for 2022 was $-0.006B, a 6.91% increase from 2021.
  • Natera annual basic eps for 2021 was $-0.005B, a 83.45% increase from 2020.
Natera Annual Basic EPS
2023 $-3.78
2022 $-5.57
2021 $-5.21
2020 $-2.84
2019 $-1.79
2018 $-2.22
2017 $-2.58
2016 $-1.95
2015 $-2.68
2014 $-1.07
2013 $-9.66
Natera Quarterly Basic EPS
2024-06-30 $-0.30
2024-03-31 $-0.56
2023-12-31 $-0.63
2023-09-30 $-0.95
2023-06-30 $-0.97
2023-03-31 $-1.23
2022-12-31 $-1.37
2022-09-30 $-1.25
2022-06-30 $-1.50
2022-03-31 $-1.45
2021-12-31 $-1.52
2021-09-30 $-1.63
2021-06-30 $-1.32
2021-03-31 $-0.74
2020-12-31 $-0.92
2020-09-30 $-0.72
2020-06-30 $-0.75
2020-03-31 $-0.45
2019-12-31 $-0.44
2019-09-30 $-0.33
2019-06-30 $-0.48
2019-03-31 $-0.54
2018-12-31 $-0.50
2018-09-30 $-0.49
2018-06-30 $-0.62
2018-03-31 $-0.61
2017-12-31 $-0.88
2017-09-30 $-0.52
2017-06-30 $-0.55
2017-03-31 $-0.63
2016-12-31 $-0.82
2016-09-30 $-0.50
2016-06-30 $-0.46
2016-03-31 $-0.17
2015-12-31 $3.18
2015-09-30 $-0.39
2015-06-30 $-3.58
2015-03-31 $-1.89
2014-12-31
2014-09-30 $0.04
2014-06-30 $-0.11
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $16.570B $1.083B
Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $98.658B 12.24
Cencora (COR) United States $49.082B 18.10
DiDi Global (DIDIY) China $23.427B 0.00
ICON (ICLR) Ireland $17.504B 15.59
Viatris (VTRS) United States $15.624B 4.81
Avantor (AVTR) United States $15.178B 22.75
Revvity (RVTY) United States $14.682B 25.50
BioMerieux (BMXMF) France $13.087B 0.00
CochLear (CHEOY) Australia $12.998B 0.00
Solventum (SOLV) United States $12.357B 0.00
Doximity (DOCS) United States $11.372B 67.31
Medpace Holdings (MEDP) United States $11.301B 31.84
Charles River Laboratories (CRL) United States $11.285B 21.81
HealthEquity (HQY) United States $8.756B 47.52
Sonic Healthcare (SKHHY) Australia $8.590B 0.00
Bausch + Lomb (BLCO) Canada $7.202B 33.53
Life Times (LTH) United States $5.139B 34.01
Sotera Health (SHC) United States $4.509B 24.12
Organon (OGN) United States $4.144B 4.18
Surgery Partners (SGRY) United States $3.996B 44.27
BrightSpring Health Services (BTSG) United States $3.489B 74.22
PACS (PACS) United States $3.347B 0.00
Alignment Healthcare (ALHC) United States $2.580B 0.00
Concentras Parent (CON) United States $2.505B 0.00
Ardent Health Partners (ARDT) United States $2.471B 0.00
Premier (PINC) United States $2.314B 11.55
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $2.016B 0.00
GoodRx Holdings (GDRX) United States $1.856B 48.90
Teladoc Health (TDOC) United States $1.689B 0.00
Progyny (PGNY) United States $1.540B 27.08
Pediatrix Medical (MD) United States $1.371B 13.41
Establishment Labs Holdings (ESTA) $1.266B 0.00
CareDx (CDNA) United States $1.252B 0.00
AMN Healthcare Services Inc (AMN) United States $1.058B 7.16
Embecta (EMBC) United States $0.910B 6.07
Agilon Health (AGL) United States $0.890B 0.00
InnovAge Holding (INNV) United States $0.809B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.723B 0.00
Auna S.A (AUNA) Luxembourg $0.516B 0.00
Sonida Senior Living (SNDA) United States $0.459B 0.00
DocGo (DCGO) United States $0.411B 15.46
Enhabit (EHAB) United States $0.403B 34.83
COMPASS Pathways (CMPS) United Kingdom $0.363B 0.00
LifeMD (LFMD) United States $0.308B 0.00
Sera Prognostics (SERA) United States $0.248B 0.00
ModivCare (MODV) United States $0.231B 12.54
Beauty Health (SKIN) United States $0.218B 0.00
Biodesix (BDSX) United States $0.205B 0.00
Nutex Health (NUTX) United States $0.152B 0.00
MultiPlan (MPLN) United States $0.137B 0.00
Ascend Wellness Holdings (AAWH) United States $0.107B 0.00
So-Young (SY) China $0.088B 21.28
Singular Genomics Systems (OMIC) United States $0.057B 0.00
Harvard Apparatus Regenerative Technology (HRGN) United States $0.054B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.042B 1.10
Co-Diagnostics (CODX) United States $0.038B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.028B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.020B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00